Background: Violence against women (VAW) is a violation of women's fundamental rights and special attention must be paid during the gestational and postpartum period. Aim: To determine the prevalence of violence against women attending antenatal and postpartum controls in Primary Health Centers. Material and Method: The Woman Abuse Screening Tool (WAST) for early detection of VAW was applied to 279 pregnant and 102 puerperal women attending five public primary health centers in metropolitan Santiago. Results: The prevalence ofviolence against pregnant and puerperal women was 5.7 and 5.9%, respectively. In both groups, the factors associated with a greater risk of violence were being immigrants, a history of domestic violence, not having a supportive partner and alcohol consumption by the partner. Conclusions: Violence against these women is a multifactorial, complex and structural phenomenon, which involves the victim, the abuser and the entire social system. Primary health care level and health professionals can be key elements applying early detection strategies, timely referral mechanisms and bringing emotional support for victims.

RESUMO A Organização Mundial da Saúde (OMS) recomenda a presença de um acompanhante durante o trabalho de parto e parto, já que essa medida melhora os resultados maternos e perinatais e a satisfação da mulher com os serviços de saúde. Para caracterizar a situação dos acompanhantes na América Latina e Caribe (ALC), realizou-se uma pesquisa on-line com membros de uma comunidade de prática de profissionais de obstetrícia e com informantes chaves para identificar: 1) a existência de instrumentos regulatórios relacionados com a presença de acompanhante nos países onde os respondentes atuam e 2) características chaves relacionadas com a implementação das políticas de acompanhantes nos locais onde existe regulamentação. Foram recebidas 112 respostas de 20 dos 43 países da ALC. Os respondentes relataram a existência de uma política ou legislação nacional em sete países, normas ministeriais ou protocolos institucionais em cinco países e nenhuma política ou protocolo em oito países. Respondentes de um mesmo país deram muitas vezes respostas contraditórias. Em 11 casos, as respostas diferiram das informações fornecidas pelos ministérios da saúde em uma pesquisa de políticas globais realizada pela OMS. Essas variações podem indicar que os profissionais nem sempre conheciam a política ou protocolo em vigor no seu país. Propõe-se a necessidade de iniciativas mais robustas para compreender a situação do acompanhante no trabalho de parto em países da ALC, em nível nacional, regional e local, tanto em instituições públicas como privadas. É importante saber se as políticas existem, em que nível do sistema existem e se as principais partes interessadas, os provedores de cuidados de saúde materna e as mulheres estão cientes de sua existência. São necessários esforços para compreender os obstáculos à implementação do sistema de acompanhante de parto.

ABSTRACT The World Health Organization (WHO) recommends a companion of choice during labor and birth, to improve maternal and perinatal outcomes and women’s satisfaction with health services. To better understand the status of companion of choice in Latin America and the Caribbean (LAC), an online survey was conducted with members of a midwifery virtual community of practice and with key informants, aiming to identify: 1) existing regulatory instruments related to companion of choice in the countries where the members are practicing; and, 2) key characteristics of implementation of companion of choice, where regulation exists. Responses (n = 112) were received from representatives of 20 of the 43 countries of LAC. Respondents reported existence of a national policy or legislation in seven countries, ministerial norms or institutional protocols in five countries, and no existing policy/protocol in eight countries. Respondents from the same country often provided contradictory responses. Responses differed from information provided by ministries of health in a WHO-led global policy survey in 11 instances. These variations may reflect that midwives were not always aware of the national policy/guideline in their country. We propose that a more robust effort should be undertaken to understand the status of companion of choice for labor and birth in LAC countries, at national, regional, and local level, in public and private facilities. It is important to know if policies exist, at what level of the system, and if key stakeholders, maternity-care health providers, and women are aware of their existence. Efforts should also be made to understand barriers to implementing companion of choice.

RESUMEN La Organización Mundial de la Salud (OMS) recomienda la presencia de un acompañante durante el trabajo de parto y el parto debido a que mejora los resultados maternos y perinatales y la satisfacción de las mujeres con los servicios de salud. Para comprender mejor la situación acerca de los acompañantes en América Latina y el Caribe (ALC) se llevó a cabo una encuesta en línea dirigida a miembros de una comunidad de práctica de partería e informantes clave con el objetivo de identificar: 1) los instrumentos regulatorios existentes relacionados con la presencia de acompañante en los países en los que ejercen las personas encuestadas y 2) las características clave relacionadas con la implementación del acompañante, en los lugares donde existe un marco regulatorio. Se recibieron 112 respuestas de 20 de los 43 países de ALC. Las personas encuestadas informaron la existencia de una política o legislación nacional en siete países, de normas ministeriales o protocolos institucionales en cinco países, y de la inexistencia de una política o un protocolo en ocho países. Las respuestas provenientes del mismo país a menudo fueron contradictorias, y en 11 casos estas difirieron de la información proporcionada por los ministerios de salud en una encuesta mundial sobre políticas dirigida por la OMS. Estas variaciones pueden reflejar que los profesionales de la partería no siempre conocían la política o el protocolo de su país. Debe emprenderse un esfuerzo más firme para comprender la situación relacionada con el acompañante durante el trabajo de parto y el parto en los países de ALC a nivel nacional, regional y local, tanto en instituciones públicas como privadas. Es importante conocer si existen políticas y en qué nivel del sistema y si los principales interesados, los prestadores de servicios de salud materna y las mujeres conocen su existencia. Se deben realizar esfuerzos para comprender los obstáculos que impiden la implementación de la presencia de un acompañante durante el parto.

Background: The Woman Abuse Screening Tool (WAST) is a screening tool for domestic violence used in Unites States. Aim: To carry out the cultural adaptation of the WAST instrument for early detection of domestic violence in primary health care. Material and Methods: Qualitative techniques for cultural adaptation were used in stages 1 and 2 and quantitative techniques were used in stage 3. The validity of content was assessed using judge tests carried out with experts in the field. Linguistic adaptation was carried out using a focal group technique to ensure semantic and language comprehension. Finally, the culturally adapted instrument was applied to 16 women who were victims of violence and to 28 women without a history of violence. Results: For cultural adaptation, the judges’ test added the item of economic violence to the instrument. According to the focus groups, some words were changed to facilitate understanding by the subjects. According to the scores obtained in women with and without a history of violence, a cut-off point of 15 points was defined to determine a history of domestic violence with a sensitivity of 100% and a specificity of 96%. The Cronbach Alpha of the questionnaire was 91%. Conclusions: WAST is an effective and easily applied instrument for the early detection of domestic violence.

Aim. To apply and validate in Chilean population "The Female Sexual Function Index" (International Consensus Development Conference on Sexual Female Dysfunctions). Design and methods. 383 sexually active healthy women between 20-59 years, beneficiaries of the Center of Health "Carol Urzúa". Instrument: questionnaire of 19 questions, contained in six domains: desire, arousal, lubrication, orgasm, satisfaction and pain. Statistical analysis: We used ANOVA, Kruskall-Wallis, squared Chi, logistical regression and Cronbach's alpha correlation coefficient. Results. Mean age: 35.3±10.9 years, married (50.4%) or cohabit (17.0%), with middle education (48.2%). The internal consistency of the test was good (>0.70). The sexuality achieves its maximum expression between 35-40 years (score: 29.1±4.9) and declines afterwards (21.0±6.0), especially desire and arousal. After 44 years old the risk of sexual disfunction increases (OR:3.6, IC: 2.1-6.3, p <0.0001). Education and having a stable couple decreases the risk (OR: 0.45, IC:0.28-0.80, p <0.005 and OR:0.58, IC:0.35-0.98, p <0.05; respectively). Conclusions. The Female Sexual Function Index is a simple applicable instrument with appropriate psicometric properties that allows us evaluate the sexuality in different stages of the life. It is adecuated for epidemiological and clinical studies

Objetivo. Aplicar y validar en una población chilena el "Indice de Función Sexual Femenina" establecido en el International Consensus Development Conference on Female Sexual Dysfunctions. Material y método. 383 mujeres sanas de 20 a 59 años con actividad sexual, beneficiarias del Centro de Salud "Carol Urzúa". Instrumento: cuestionario de 19 preguntas, agrupadas en seis dominios: deseo, excitación, lubricación, orgasmo, satisfacción y dolor. Análisis estadístico: Se utilizó ANOVA, Kruskall-Wallis, Chi cuadrado, regresión logística y alpha de Cronbach. Resultados. Edad media: 35,3±10,9 años, casadas (50,4%) o conviviente (17,0%), con educación media (48,2%). La consistencia interna del test fue buena (>0,70). La sexualidad logra su máxima expresión a los 35-40 años (puntaje: 29,1±4,9) para caer posteriormente (21,0±6,0), especialmente el deseo y excitación. Después de los 44 años se incrementa el riesgo de disfunción sexual (OR:3,6; IC: 2,1-6,3; p< 0,0001). La mayor educación y la estabilidad de pareja disminuyen el riesgo (OR: 0,45; IC:0,28-0,80; p< 0,005 y OR:0,58; IC:0,35-0,98; p< 0,05 respectivamente). Conclusiones. El Indice de Función Sexual Femenino es un instrumento sencillo de aplicar, con propiedades psicométricas adecuadas que permite evaluar la sexualidad en diferentes etapas de la vida. Es adecuado para estudios epidemiológicos y clínicos

It is generally accepted that menopause significantly modifies cardiovascular risk. The effects of hormone replacement therapy (HRT) on this risk remain controversial. Aim: To study the prevalence of cardiovascular risk factors (RF) in middle-aged women and their changes with aging, menopause and hormone replacement therapy (HRT). Material and methods: cardiovascular risk factors were assessed in 576 women aged 40 to 59 years in 1991-92. Five years later, 467 of these women were reassessed. Results: Sedentarism (87.2%), dyslipidemias (71.5%), high blood pressure (13.5%), obesity (13.1%), smoking (12.4%) and diabetes (2.8%) were the most prevalent RF. Five years later, the prevalence of hypertension increased to 20.9%, the prevalence of obesity increased to 27.3%, smoking increased to 20.8% and diabetes to 5.9%. The prevalence of dyslipidemia did not change, although triglycerides levels rose from 125.9±56.4 to 136.8±63.5 mg/dl (p <0.001). Sedentarism dropped to 58.8%. Menopause did not deteriorate any of these RF. The use of HRT increased during the 5 years follow-up from 3.8% to 35%. Women on HRT experienced 3% decrease in LDL-cholesterol and 9% increase in HDL-cholesterol levels. Conclusions: Middle aged women included in this cohort have a high prevalence of RF. There is a deterioration with age, but not with menopause. HRT improves the lipid profile (Rev Méd Chile 2003; 131: 381-9).